BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 17996702)

  • 1. Crystal structure of the retinoblastoma protein N domain provides insight into tumor suppression, ligand interaction, and holoprotein architecture.
    Hassler M; Singh S; Yue WW; Luczynski M; Lakbir R; Sanchez-Sanchez F; Bader T; Pearl LH; Mittnacht S
    Mol Cell; 2007 Nov; 28(3):371-85. PubMed ID: 17996702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The N Terminus of the Retinoblastoma Protein Inhibits DNA Replication via a Bipartite Mechanism Disrupted in Partially Penetrant Retinoblastomas.
    Borysov SI; Nepon-Sixt BS; Alexandrow MG
    Mol Cell Biol; 2015 Dec; 36(5):832-45. PubMed ID: 26711265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural similarity between the pocket region of retinoblastoma tumour suppressor and the cyclin-box.
    Kim HY; Cho Y
    Nat Struct Biol; 1997 May; 4(5):390-5. PubMed ID: 9145110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure of the Rb C-terminal domain bound to E2F1-DP1: a mechanism for phosphorylation-induced E2F release.
    Rubin SM; Gall AL; Zheng N; Pavletich NP
    Cell; 2005 Dec; 123(6):1093-106. PubMed ID: 16360038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structures of inactive retinoblastoma protein reveal multiple mechanisms for cell cycle control.
    Burke JR; Hura GL; Rubin SM
    Genes Dev; 2012 Jun; 26(11):1156-66. PubMed ID: 22569856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure of the retinoblastoma tumour-suppressor pocket domain bound to a peptide from HPV E7.
    Lee JO; Russo AA; Pavletich NP
    Nature; 1998 Feb; 391(6670):859-65. PubMed ID: 9495340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Temperature-sensitive RB mutations linked to incomplete penetrance of familial retinoblastoma in 12 families.
    Otterson GA; Modi S; Nguyen K; Coxon AB; Kaye FJ
    Am J Hum Genet; 1999 Oct; 65(4):1040-6. PubMed ID: 10486322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Separation of anti-proliferation and anti-apoptotic functions of retinoblastoma protein through targeted mutations of its A/B domain.
    Chau BN; Pan CW; Wang JY
    PLoS One; 2006 Dec; 1(1):e82. PubMed ID: 17183714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conservation and divergence of C-terminal domain structure in the retinoblastoma protein family.
    Liban TJ; Medina EM; Tripathi S; Sengupta S; Henry RW; Buchler NE; Rubin SM
    Proc Natl Acad Sci U S A; 2017 May; 114(19):4942-4947. PubMed ID: 28439018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dimerization of CtIP may stabilize in vivo interactions with the Retinoblastoma-pocket domain.
    Stokes PH; Thompson LS; Marianayagam NJ; Matthews JM
    Biochem Biophys Res Commun; 2007 Mar; 354(1):197-202. PubMed ID: 17214969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phosphorylation-induced conformational changes in the retinoblastoma protein inhibit E2F transactivation domain binding.
    Burke JR; Deshong AJ; Pelton JG; Rubin SM
    J Biol Chem; 2010 May; 285(21):16286-93. PubMed ID: 20223825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An overlapping kinase and phosphatase docking site regulates activity of the retinoblastoma protein.
    Hirschi A; Cecchini M; Steinhardt RC; Schamber MR; Dick FA; Rubin SM
    Nat Struct Mol Biol; 2010 Sep; 17(9):1051-7. PubMed ID: 20694007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Domains A and B in the Rb pocket interact to form a transcriptional repressor motif.
    Chow KN; Dean DC
    Mol Cell Biol; 1996 Sep; 16(9):4862-8. PubMed ID: 8756645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural basis for the recognition of the E2F transactivation domain by the retinoblastoma tumor suppressor.
    Lee C; Chang JH; Lee HS; Cho Y
    Genes Dev; 2002 Dec; 16(24):3199-212. PubMed ID: 12502741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The DnaJ domain of polyomavirus large T antigen is required to regulate Rb family tumor suppressor function.
    Sheng Q; Denis D; Ratnofsky M; Roberts TM; DeCaprio JA; Schaffhausen B
    J Virol; 1997 Dec; 71(12):9410-6. PubMed ID: 9371601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Crystal structure of the homolog of the oncoprotein gankyrin, an interactor of Rb and CDK4/6.
    Padmanabhan B; Adachi N; Kataoka K; Horikoshi M
    J Biol Chem; 2004 Jan; 279(2):1546-52. PubMed ID: 14583612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The amino terminus of the retinoblastoma (Rb) protein associates with a cyclin-dependent kinase-like kinase via Rb amino acids required for growth suppression.
    Sterner JM; Tao Y; Kennett SB; Kim HG; Horowitz JM
    Cell Growth Differ; 1996 Jan; 7(1):53-64. PubMed ID: 8788033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A potent transrepression domain in the retinoblastoma protein induces a cell cycle arrest when bound to E2F sites.
    Sellers WR; Rodgers JW; Kaelin WG
    Proc Natl Acad Sci U S A; 1995 Dec; 92(25):11544-8. PubMed ID: 8524800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The central acidic domain of MDM2 is critical in inhibition of retinoblastoma-mediated suppression of E2F and cell growth.
    Sdek P; Ying H; Zheng H; Margulis A; Tang X; Tian K; Xiao ZX
    J Biol Chem; 2004 Dec; 279(51):53317-22. PubMed ID: 15485814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retinoblastoma protein is functionally distinct from its homologues in affecting glucocorticoid receptor-mediated transcription and apoptosis.
    Singh P; Chan SW; Hong W
    J Biol Chem; 2001 Apr; 276(17):13762-70. PubMed ID: 11279017
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.